16 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
business information and personal information including health information), and could result in financial, legal, business and reputational harm to VBL … and regulations, which, in the event of a violation, could expose Notable to criminal sanctions, civil penalties, contractual damages, reputational harm
S-4/A
oansna758 lvd3s
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
10-Q
y76cot fm7o9bd3m3
15 May 23
Quarterly report
4:30pm
S-4
yars8
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.3
nti71rgudz2y6x57y8p
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.3
brz8t271h1w
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
20-F
om9uts
25 Mar 15
Annual report (foreign)
12:00am
424B4
i27eykk5 x72ucj6
2 Oct 14
Prospectus supplement with pricing info
12:00am
FWP
zy97p
30 Sep 14
Free writing prospectus
12:00am
- Prev
- 1
- Next